Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay V Maker

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Cancers|November 26, 2022
Minimally Invasive Distal Pancreatectomy Techniques: A Contemporary Analysis Exploring Trends, Similarities, and Differences to Open SurgeryFernanda Romero-Hernandez, Sarah Mohamedaly, Phoebe Miller, et al.
World Journal of Surgery|November 19, 2022
Hand-Assisted Versus Pure Minimally-Invasive Distal Pancreatectomy: Is There a Downside to Lending a Hand?Phoebe N Miller, Fernanda Romero-Hernandez, Patricia Conroy, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC)Han Yin, Fernanda Romero-Hernandez, Amir Ashraf Ganjouei, et al.
The Lancet. Gastroenterology & Hepatology|September 3, 2022
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasmsTommaso Pollini, Volcan Adsay, Gabriele Capurso, et al.
Journal of Surgical Oncology|August 11, 2021
Attrition during neoadjuvant chemotherapy for gastric adenocarcinoma is associated with decreased survival: A United States Safety-Net Collaborative analysisJoshua P Kronenfeld, Amber L Collier, Michael K Turgeon, et al.
Journal of Surgical Oncology|July 27, 2025
Minimally Invasive Versus Open Resection for Solid Pseudopapillary Tumors of the Pancreas: A Propensity Score-Matched AnalysisPaul Wong, Letizia Todeschini, Tommaso Pollini, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanomaAjay V Maker, James C Yang, Richard M Sherry, et al.
Annals of Surgical Oncology|November 12, 2005
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II studyAjay V Maker, Giao Q Phan, Peter Attia, et al.
JAMA Network Open|June 26, 2026
Serum CA19.9 for Detecting High-Grade Dysplasia and Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasm: A Systematic Review and Meta-AnalysisCharlotte A Leseman, Alessandro M Bonomi, Job Schuitema, et al.
Journal of Surgical Oncology|June 1, 2021
Is there a difference in utilization of a perioperative treatment approach for gastric cancer between safety net hospitals and tertiary referral centers?Michael K Turgeon, Rachel M Lee, Jessica M Keilson, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Cancers|November 26, 2022
Minimally Invasive Distal Pancreatectomy Techniques: A Contemporary Analysis Exploring Trends, Similarities, and Differences to Open SurgeryFernanda Romero-Hernandez, Sarah Mohamedaly, Phoebe Miller, et al.
World Journal of Surgery|November 19, 2022
Hand-Assisted Versus Pure Minimally-Invasive Distal Pancreatectomy: Is There a Downside to Lending a Hand?Phoebe N Miller, Fernanda Romero-Hernandez, Patricia Conroy, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
Adult Pancreatoblastoma: Clinical Insights and Outcomes Compared to Pancreatic Ductal Adenocarcinoma (PDAC)Han Yin, Fernanda Romero-Hernandez, Amir Ashraf Ganjouei, et al.
The Lancet. Gastroenterology & Hepatology|September 3, 2022
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasmsTommaso Pollini, Volcan Adsay, Gabriele Capurso, et al.
Journal of Surgical Oncology|August 11, 2021
Attrition during neoadjuvant chemotherapy for gastric adenocarcinoma is associated with decreased survival: A United States Safety-Net Collaborative analysisJoshua P Kronenfeld, Amber L Collier, Michael K Turgeon, et al.
Journal of Surgical Oncology|July 27, 2025
Minimally Invasive Versus Open Resection for Solid Pseudopapillary Tumors of the Pancreas: A Propensity Score-Matched AnalysisPaul Wong, Letizia Todeschini, Tommaso Pollini, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanomaAjay V Maker, James C Yang, Richard M Sherry, et al.
Annals of Surgical Oncology|November 12, 2005
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II studyAjay V Maker, Giao Q Phan, Peter Attia, et al.
JAMA Network Open|June 26, 2026
Serum CA19.9 for Detecting High-Grade Dysplasia and Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasm: A Systematic Review and Meta-AnalysisCharlotte A Leseman, Alessandro M Bonomi, Job Schuitema, et al.
Journal of Surgical Oncology|June 1, 2021
Is there a difference in utilization of a perioperative treatment approach for gastric cancer between safety net hospitals and tertiary referral centers?Michael K Turgeon, Rachel M Lee, Jessica M Keilson, et al.
Pageof 14